title: The introduction of new vaccines into developing countries. IV: Global Access Strategies.
abstract: This paper offers a framework for managing a comprehensive Global Access Strategy for new vaccines in developing countries. It is aimed at strengthening the ability of public-sector entities to reach their goals. The Bill and Melinda Gates Foundation and The Rockefeller Foundation have been leaders in stimulating the creation of new organizations - public/private product development partnerships (PDPs) - that seek to accelerate vaccine development and distribution to meet the health needs of the world's poor. Case studies of two of these PDPs - the Salmonella Anti-pneumococcal Vaccine Program and the Pediatric Dengue Vaccine Initiative - examine development of such strategies. Relying on the application of innovation theory, the strategy leads to the identification of six Components of Innovation which cover all aspects of the vaccine innovation process. Appropriately modified, the proposed framework can be applied to the development and introduction of other products in developing countries including drugs, and nutritional and agricultural products.
authors.affiliation: Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea. rmahoney@pdvi.org
authors.forename: Richard T
authors.initials: RT
authors.lastname: Mahoney
authors.forename: Anatole
authors.initials: A
authors.lastname: Krattiger
authors.forename: John D
authors.initials: JD
authors.lastname: Clemens
authors.forename: Roy
authors.initials: R
authors.lastname: Curtiss
mesh_terms: D053059:Dengue Vaccines / Q000008:administration & dosage / Q000191:economics; D003906:Developing Countries; D014943:Global Health; D006285:Health Planning / Q000379:methods / Q000458:organization & administration; D006297:Health Services Accessibility; D017589:Immunization Programs / Q000191:economics / Q000458:organization & administration*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000191:economics; D018410:Pneumonia, Bacterial / Q000191:economics / Q000517:prevention & control; D017149:Private Sector / Q000191:economics; D017150:Public Sector / Q000191:economics; D014612:Vaccines / Q000008:administration & dosage* / Q000191:economics
chemical_list: D053059:Dengue Vaccines; D022242:Pneumococcal Vaccines; D014612:Vaccines